Osteogenesis Imperfecta (OI) is a genetic bone disorder characterized by fragile bones that break easily. It is also known as “brittle bone disease.”DONATE
The Foundation is continually developing new information resources in response to the needs of families, individuals, and professionals working with those affected by OI.
The OI Foundation provides additional resources including the OI Clinic Directory, OIF Newsletters, and Support Networks.
OIF Regional Conferences, and OI support group meetings are held across the country. Attend an upcoming event in your area!
NIH Grant Funds Brittle Bone Disorders Consortium
As the lead patient advocacy organization of the Brittle Bone Disorders Consortium (BBDC), part of the NIH’s Rare Diseases Clinical Research Network, the OIF is pleased to announce that the BBDC has been funded for an additional five years.Learn More
OIF's Good Stuff Sweepstakes
The OIF Good Stuff Sweepstakes is now open! Enter today for your chance to win a Ring Video Doorbell 2, a trip to the July 2020 OIF National Conference in Omaha, NE, or an American Express gift card!Enter Now!
OIF National Conference
The OI Foundation and OI community will celebrate the OIF’s 50th anniversary at the OIF National Conference on July 9-12, 2020 in Omaha, Nebraska. We hope to see you there!Learn More
Sign up to receive the OI Foundation's monthly E-Newsletter!
Leaders in the OI field discuss Multidisciplinary Care, Pregnancy in Women with OI, Pulmonary Issues, Transitioning from Pediatric to Adult Care, Dental Issues, Spinal Issues, and more on the OIF Podcast Series. Listen, learn, share!
Fundraising events, OIF Regional Conferences, and OI support group meetings are held across the country. Attend an upcoming event in your area!
Supporting research is an important part of the OI Foundation’s mission. Your participation in current studies helps move OI research forward.
The OIF is proud to be a member of the Rare Bone Disease Alliance (RBDA). The RBDA is a patient advocacy network focused on educating medical professionals, expanding research, and assisting patients and communities affected by rare bone diseases.